المؤلفون: Gridelli C., Morabito A., Cavanna L., Luciani A., Maione P., Bonanno L., Filipazzi V., Leo S., Cinieri S., Ciardiello F., Burgio M. A., Bilancia D., Cortinovis D., Rosetti F., Bianco R., Gebbia V., Artioli F., Bordonaro R., Fregoni V., Mencoboni M., Nelli F., Riccardi F., Di Isernia G., Costanzo R., Rocco G., Daniele G., Signoriello S., Piccirillo M. C., Gallo C., Perrone F.

المساهمون: Gridelli, C., Morabito, A., Cavanna, L., Luciani, A., Maione, P., Bonanno, L., Filipazzi, V., Leo, S., Cinieri, S., Ciardiello, F., Burgio, M. A., Bilancia, D., Cortinovis, D., Rosetti, F., Bianco, R., Gebbia, V., Artioli, F., Bordonaro, R., Fregoni, V., Mencoboni, M., Nelli, F., Riccardi, F., Di Isernia, G., Costanzo, R., Rocco, G., Daniele, G., Signoriello, S., Piccirillo, M. C., Gallo, C., Perrone, F.

مصطلحات موضوعية: Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Non-Small-Cell Lung, Cisplatin, Deoxycytidine, Female, Human, Kaplan-Meier Estimate, Lung Neoplasm, Male, Pemetrexed, Quality of Life, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000445669200004; volume:36; issue:25; firstpage:2585; lastpage:2592; numberofpages:8; journal:JOURNAL OF CLINICAL ONCOLOGY; http://hdl.handle.net/11588/823700Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85052571799

الإتاحة: https://doi.org/10.1200/JCO.2017.76.8390Test
http://hdl.handle.net/11588/823700Test

المؤلفون: Van Cutsem, E, Yoshino, T, Lenz, H J, Lonardi, S, Falcone, A, Limón, M L, Saunders, M, Sobrero, A, Park, Y S, Ferreiro, R, Hong, Y S, Tomasek, J, Taniguchi, H, Ciardiello, F, Stoehr, J, Oum'Hamed, Z, Vlassak, S, Studeny, M, Argiles, G

مصطلحات موضوعية: Adenocarcinoma, Administration, Oral, Adult, Aged, Antineoplastic Agents, Chemical and Drug Induced Liver Injury, Colorectal Neoplasms, Disease Progression, Double-Blind Method, Fatigue, Female, Humans, Indoles, Male, Middle Aged, Placebos, Progression-Free Survival, Protein Kinase Inhibitors, Receptors, Vascular Endothelial Growth Factor, Response Evaluation Criteria in Solid Tumors

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/10668/12712Test; PMC6158765; https://doi.org/10.1093/annonc/mdy241Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158765/pdfTest

الإتاحة: https://doi.org/10.1093/annonc/mdy241Test
http://hdl.handle.net/10668/12712Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6158765/pdfTest

المؤلفون: Siena S., Di Bartolomeo M., Raghav K., Masuishi T., Loupakis F., Kawakami H., Yamaguchi K., Nishina T., Fakih M., Elez E., Rodriguez J., Ciardiello F., Komatsu Y., Esaki T., Chung K., Wainberg Z., Sartore-Bianchi A., Saxena K., Yamamoto E., Bako E., Okuda Y., Shahidi J., Grothey A., Yoshino T.

المساهمون: Siena, S., Di Bartolomeo, M., Raghav, K., Masuishi, T., Loupakis, F., Kawakami, H., Yamaguchi, K., Nishina, T., Fakih, M., Elez, E., Rodriguez, J., Ciardiello, F., Komatsu, Y., Esaki, T., Chung, K., Wainberg, Z., Sartore-Bianchi, A., Saxena, K., Yamamoto, E., Bako, E., Okuda, Y., Shahidi, J., Grothey, A., Yoshino, T.

مصطلحات موضوعية: Adult, Aged, Antibodies, Monoclonal, Humanized, Camptothecin, Colorectal Neoplasm, Female, Human, Immunoconjugate, Italy, Japan, Male, Maximum Tolerated Dose, Middle Aged, Neoplasm Metastasi, Receptor, ErbB-2, Spain, Trastuzumab

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33961795; info:eu-repo/semantics/altIdentifier/wos/WOS:000657432100046; volume:22; issue:6; firstpage:779; lastpage:789; numberofpages:11; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/11591/452991Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105300772

الإتاحة: https://doi.org/10.1016/S1470-2045Test(21)00086-3
http://hdl.handle.net/11591/452991Test

المؤلفون: Cremolini C., Antoniotti C., Rossini D., Lonardi S., Loupakis F., Pietrantonio F., Bordonaro R., Latiano T. P., Tamburini E., Santini D., Passardi A., Marmorino F., Grande R., Aprile G., Zaniboni A., Murgioni S., Granetto C., Buonadonna A., Moretto R., Corallo S., Cordio S., Antonuzzo L., Tomasello G., Masi G., Ronzoni M., Di Donato S., Carlomagno C., Clavarezza M., Ritorto G., Mambrini A., Roselli M., Cupini S., Mammoliti S., Fenocchio E., Corgna E., Zagonel V., Fontanini G., Ugolini C., Boni L., Falcone A., De Braud F. G. M., Maiello E., Frassineti G. L., Gamucci T., Di Costanzo F., Gianni L., Racca P., Allegrini G., Sobrero A., Aglietta M., Cortesi E., Corsi D. C., Ballestrero A., Bonetti A., Di Clemente F., Ruggeri E., Ciardiello F., Benasso M., Vitello S., Cinieri S., Mosconi S., Silvestris N., Frassoldati A., Bertolini A., Tortora G., Bengala C., Ferrari D., Ardizzoia A., Milandri C., Chiara S., Romano G., Miraglia S., Scaltriti L., Pucci F., Blasi L., Brugnatelli S., Fioretto L., Ribecco A. S., Longarini R., Frisinghelli M., Banzi M.

المساهمون: Cremolini, C., Antoniotti, C., Rossini, D., Lonardi, S., Loupakis, F., Pietrantonio, F., Bordonaro, R., Latiano, T. P., Tamburini, E., Santini, D., Passardi, A., Marmorino, F., Grande, R., Aprile, G., Zaniboni, A., Murgioni, S., Granetto, C., Buonadonna, A., Moretto, R., Corallo, S., Cordio, S., Antonuzzo, L., Tomasello, G., Masi, G., Ronzoni, M., Di Donato, S., Carlomagno, C., Clavarezza, M., Ritorto, G., Mambrini, A., Roselli, M., Cupini, S., Mammoliti, S., Fenocchio, E., Corgna, E., Zagonel, V., Fontanini, G., Ugolini, C., Boni, L., Falcone, A., De Braud, F. G. M., Maiello, E., Frassineti, G. L., Gamucci, T., Di Costanzo, F., Gianni, L., Racca, P., Allegrini, G., Sobrero, A., Aglietta, M., Cortesi, E., Corsi, D. C., Ballestrero, A., Bonetti, A., Di Clemente, F., Ruggeri, E., Ciardiello, F., Benasso, M., Vitello, S., Cinieri, S., Mosconi, S., Silvestris, N., Frassoldati, A., Bertolini, A., Tortora, G., Bengala, C., Ferrari, D., Ardizzoia, A., Milandri, C., Chiara, S., Romano, G., Miraglia, S., Scaltriti, L., Pucci, F., Blasi, L., Brugnatelli, S., Fioretto, L., Ribecco, A. S., Longarini, R., Frisinghelli, M., Banzi, M.

مصطلحات موضوعية: Adolescent, Adult, Aged, Antineoplastic Agents, Immunological, Antineoplastic Combined Chemotherapy Protocol, Bevacizumab, Camptothecin, Colorectal Neoplasm, Disease Progression, Female, Fluorouracil, Human, Leucovorin, Male, Middle Aged, Neoplasm Metastasi, Organoplatinum Compound, Young Adult

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/32164906; info:eu-repo/semantics/altIdentifier/wos/WOS:000522625000026; volume:21; issue:4; firstpage:497; lastpage:507; numberofpages:11; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/11591/432744Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85082493423

الإتاحة: https://doi.org/10.1016/S1470-2045Test(19)30862-9
http://hdl.handle.net/11591/432744Test

المؤلفون: Cremolini C., Rossini D., Martinelli E., Pietrantonio F., Lonardi S., Noventa S., Tamburini E., Frassineti G. L., Mosconi S., Nichetti F., Murgioni S., Troiani T., Borelli B., Zucchelli G., Dal Maso A., Sforza V., Masi G., Antoniotti C., Di Bartolomeo M., Miceli R., Ciardiello F., Falcone A.

المساهمون: Cremolini, C., Rossini, D., Martinelli, E., Pietrantonio, F., Lonardi, S., Noventa, S., Tamburini, E., Frassineti, G. L., Mosconi, S., Nichetti, F., Murgioni, S., Troiani, T., Borelli, B., Zucchelli, G., Dal Maso, A., Sforza, V., Masi, G., Antoniotti, C., Di Bartolomeo, M., Miceli, R., Ciardiello, F., Falcone, A.

مصطلحات موضوعية: Refractory colorectal cancer, Regorafenib, TAS-102, Trifluridine/tipiracil, Adult, Aged, 80 and over, Colorectal Neoplasm, Drug Combination, Female, Human, Italy, Male, Middle Aged, Progression-Free Survival, Pyrrolidine, Registrie, Thymine, Trifluridine, Uracil

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/29739893; info:eu-repo/semantics/altIdentifier/wos/WOS:000447162800012; volume:23; issue:10; firstpage:1178; lastpage:1187; numberofpages:10; journal:THE ONCOLOGIST; http://hdl.handle.net/11577/3391533Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85054898264

الإتاحة: https://doi.org/10.1634/theoncologist.2017-0573Test
http://hdl.handle.net/11577/3391533Test

المؤلفون: De Placido S., Gallo C., De Laurentiis M., Bisagni G., Arpino G., Sarobba M. G., Riccardi F., Russo A., Del Mastro L., Cogoni A. A., Cognetti F., Gori S., Foglietta J., Frassoldati A., Amoroso D., Laudadio L., Moscetti L., Montemurro F., Verusio C., Bernardo A., Lorusso V., Gravina A., Moretti G., Lauria R., Lai A., Mocerino C., Rizzo S., Nuzzo F., Carlini P., Perrone F., Accurso A., Agostara B., Aieta M., Alabiso O., Alicicco M. G., Amadori D., Amaducci L., Amiconi G., Antuzzi G., Ardine M., Ardizzoia A., Aversa C., Badalamenti G., Barni S., Basurto C., Berardi R., Bergamasco C., Bidoli P., Bighin C., Biondi E., Boni C., Borgonovo K., Botta M., Bravi S., Bruzzi P., Buono G., Butera A., Caldara A., Candeloro G., Cappelletti C., Cardalesi C., Carfora E., Cariello A., Carrozza F., Carteni G., Caruso M., Casadei V., Casanova C., Castori L., Cavanna L., Cavazzini G., Cazzaniga M., Chilelli M., Chiodini P., Chiorrini S., Ciardiello F., Ciccarese M., Cinieri S., Clerico M., Coccaro M., Comande M., Corbo C., Cortino G., Cusenza S., Daniele G., D'arco A. M., D'auria G., Dazzi C., De Angelis C., de Braud F., De Feo G., De Matteis MA., De Tursi M., Di Blasio A., di Lucca G., Di Lullo L., Di Rella F., Di Renzo G., Di Stefano P., Di Stefano A., Diana A., Donati S., Fabbri A., Fabi A., Faedi M., Farina G., Farris A., Febbraro A., Fedele P., Federico P., Ferrau F., Ferretti G., Ferro A., Floriani I., Forcignano R., Forciniti S., Forestieri V., Fornari G., Frisinghelli M., Fusco V., Gallizzi G., Galvano A., Gambardella A., Gambi A., Gebbia V., Gervasi E., Ghilardi M., Giacobino A., Giardina G., Giotta F., Giraudi S., Giuliano M., Grassadonia A., Grasso D., Grosso F., Guizzaro L., Incoronato P., Incorvaia L., Iodice G., La Verde N., Labonia V., Landi G., Latorre A., Leonardi V., Levaggi A., Limite G., Lina Bascialla L., Livi L., Maiello E., Mandelli D., Marcon I., Menon D., Montedoro M., Moraca L., Moretti A., Morritti M. G., Morselli P., Mura A., Mura S., Musacchio M., Muzio A., Natale D., Natoli C., Nigro C., Nistico C., Nuzzo A., Orditura M., Orlando L., Pacilio C., Palumbo G., Palumbo R., Pasini F., Paterno E., Pazzola A., Pelliccioni S., Pensabene M., Perroni D., Pesenti Gritti A., Petrelli F., Piccirillo M. C., Pinotti G., Pogliani C., Poli D., Prader S., Recchia F., Rizzi D., Romano C., Rossello R., Rossini C., Salvucci G., Sanna V., Santini A., Saracchini S., Savastano C., Scambia G., Schettini F., Schiavone P., Schirone A., Seles E., Signoriello S., Signoriello G., Silva R. R., Silvestri A., Simeon V., Spagnoletti I., Tamberi S., Teragni C., Thalmann V., Thomas R., Thomas G., Tienghi A., Tinari N., Tinessa V., Tomei F., Tonini G., Torri V., Traficante D., Tudini M., Turazza M., Vignoli R., Vitale M. G., Zacchia A., Zagarese P., Zanni A., Zavallone L., Zavettieri M., Zoboli A.

المساهمون: De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A., Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F., Accurso, A., Agostara, B., Aieta, M., Alabiso, O., Alicicco, M. G., Amadori, D., Amaducci, L., Amiconi, G., Antuzzi, G., Ardine, M., Ardizzoia, A., Aversa, C., Badalamenti, G., Barni, S., Basurto, C., Berardi, R., Bergamasco, C., Bidoli, P., Bighin, C., Biondi, E., Boni, C., Borgonovo, K., Botta, M., Bravi, S., Bruzzi, P., Buono, G., Butera, A., Caldara, A., Candeloro, G., Cappelletti, C., Cardalesi, C., Carfora, E., Cariello, A., Carrozza, F., Carteni, G., Caruso, M., Casadei, V., Casanova, C., Castori, L., Cavanna, L., Cavazzini, G., Cazzaniga, M., Chilelli, M., Chiodini, P., Chiorrini, S., Ciardiello, F., Ciccarese, M., Cinieri, S., Clerico, M., Coccaro, M., Comande, M., Corbo, C., Cortino, G., Cusenza, S., Daniele, G., D'Arco, A. M., D'Auria, G., Dazzi, C., De Angelis, C., de Braud, F., De Feo, G., De Matteis, Ma., De Tursi, M., Di Blasio, A., di Lucca, G., Di Lullo, L., Di Rella, F., Di Renzo, G., Di Stefano, P.

مصطلحات موضوعية: Aged, Anastrozole, Androstadiene, Antineoplastic Combined Chemotherapy Protocol, Aromatase Inhibitor, Breast Neoplasm, Chemotherapy, Adjuvant, Disease-Free Survival, Drug Administration Schedule, Female, Human, Letrozole, Middle Aged, Receptor, ErbB-2, Receptors, Estrogen, Progesterone, Tamoxifen

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000428790400036; volume:19; issue:4; firstpage:474; lastpage:485; numberofpages:12; journal:THE LANCET ONCOLOGY; http://hdl.handle.net/11588/789500Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85042358192; http://www.journals.elsevier.com/the-lancet-oncologyTest/

الإتاحة: https://doi.org/10.1016/S1470-2045Test(18)30116-5
http://hdl.handle.net/11588/789500Test
http://www.journals.elsevier.com/the-lancet-oncologyTest/

المؤلفون: De Vita F., Ventriglia J., Febbraro A., Laterza M. M., Fabozzi A., Savastano B., Petrillo A., Diana A., Giordano G., Troiani T., Conzo G., Galizia G., Ciardiello F., Orditura M.

المساهمون: De Vita, F., Ventriglia, J., Febbraro, A., Laterza, M. M., Fabozzi, A., Savastano, B., Petrillo, A., Diana, A., Giordano, G., Troiani, T., Conzo, G., Galizia, G., Ciardiello, F., Orditura, M.

مصطلحات موضوعية: Combination chemotherapy, Gemcitabine, Metastatic pancreatic cancer, Nab-paclitaxel, Adult, Aged, Albumin, Antineoplastic Combined Chemotherapy Protocol, Carcinoma, Pancreatic Ductal, Compassionate Use Trial, Deoxycytidine, Drug Administration Schedule, Female, Human, Male, Middle Aged, Neoplasm Metastasi, Paclitaxel, Pancreatic Neoplasm, Randomized Controlled Trials as Topic, Retrospective Studie, Survival Analysi, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27590845; info:eu-repo/semantics/altIdentifier/wos/WOS:000384283300001; volume:16; issue:1; firstpage:709; journal:BMC CANCER; http://hdl.handle.net/11369/393403Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84984999017

الإتاحة: https://doi.org/10.1186/s12885-016-2671-9Test
http://hdl.handle.net/11369/393403Test

المؤلفون: Peters, S., Stahel, R.A., Dafni, U., Ponce Aix, S., Massutí, B., Gautschi, O., Coate, L., López Martín, A., van Heemst, R., Berghmans, T., Meldgaard, P., Cobo Dols, M., Garde Noguera, J., Curioni-Fontecedro, A., Rauch, D., Mark, M.T., Cuffe, S., Biesma, B., van Henten, AMJ, Juan Vidal, Ó., Palmero Sanchez, R., Villa Guzmán, J.C., Collado Martin, R., Peralta, S., Insa, A., Summers, Y., Láng, I., Horgan, A., Ciardiello, F., de Hosson, S., Pieterman, R., Groen, HJM, van den Berg, P.M., Zielinski, C.C., Chittazhathu Kurian Kuruvilla, Y., Gasca-Ruchti, A., Kassapian, M., Novello, S., Torri, V., Tsourti, Z., Gregorc, V., Smit, E.F.

المساهمون: EMPHASIS-lung Collaborative Group

المصدر: Journal of thoracic oncology, vol. 12, no. 4, pp. 752-762

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carcinoma, Non-Small-Cell Lung/drug therapy, Non-Small-Cell Lung/pathology, Squamous Cell/drug therapy, Squamous Cell/pathology, Cohort Studies, Erlotinib Hydrochloride/administration & dosage, Female, Follow-Up Studies, Humans, Lung Neoplasms/drug therapy, Lung Neoplasms/pathology, Male, Neoplasm Staging, Platinum/administration & dosage, Prognosis, Survival Rate, Taxoids/administration & dosage, Docetaxel, ETOP, Erlotinib, NSCLC, Squamous, VeriStrat

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/28017787; info:eu-repo/semantics/altIdentifier/eissn/1556-1380; https://serval.unil.ch/notice/serval:BIB_D30A1C513C0CTest; urn:issn:1556-0864

الإتاحة: https://doi.org/10.1016/j.jtho.2016.12.017Test
https://serval.unil.ch/notice/serval:BIB_D30A1C513C0CTest

المؤلفون: Peters S, Stahel RA, Dafni U, Ponce Aix S, Massutí B, Gautschi O, Coate L, López Martín A, van Heemst R, Berghmans T, Meldgaard P, Cobo Dols M, Garde Noguera J, Curioni-Fontecedro A, Rauch D, Mark MT, Cuffe S, Biesma B, van Henten AMJ, Juan Vidal Ó, Palmero Sanchez R, Villa Guzmán JC, Collado Martin R, Peralta S, Insa A, Summers Y, Láng I, Horgan A, Ciardiello F, de Hosson S, Pieterman R, Groen HJM, van den Berg PM, Zielinski CC, Chittazhathu Kurian Kuruvilla Y, Gasca-Ruchti A, Kassapian M, Novello S, Torri V, Tsourti Z, Gregorc V, Smit EF, EMPHASIS-lung Collaborative Group

المساهمون: Pulmonary medicine, CCA - Cancer Treatment and quality of life, Peters, S, Stahel, Ra, Dafni, U, Aix, Sp, Massutí, B, Gautschi, O, Coate, L, López Martín, A, Van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Noguera, Jg, Curioni Fontecedro, A, Rauch, D, Mark, Mt, Cuffe, S, Biesma, B, Van Henten, Am, Vidal, Ój, Sanchez, Rp, Villa Guzmán, Jc, Martin, Rc, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, Fortunato, De Hosson, S, Pieterman, R, Groen, Hj, Van Den Berg, Pm, Zielinski, Cc, Kuruvilla, Yc, Gasca Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, Ef, EMPHASIS lung collaborative, Group

المصدر: JOURNAL OF THORACIC ONCOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Journal of Thoracic Oncology, 12(4), 752-762. International Association for the Study of Lung Cancer
Peters, S, Stahel, R A, Dafni, U, Ponce Aix, S, Massutí, B, Gautschi, O, Coate, L, López Martín, A, van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Garde Noguera, J, Curioni-Fontecedro, A, Rauch, D, Mark, M T, Cuffe, S, Biesma, B, van Henten, A M J, Juan Vidal, Ó, Palmero Sanchez, R, Villa Guzmán, J C, Collado Martin, R, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, F, de Hosson, S, Pieterman, R, Groen, H J M, van den Berg, P M, Zielinski, C C, Chittazhathu Kurian Kuruvilla, Y, Gasca-Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, E F & EMPHASIS-lung Collaborative Group 2017, ' Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial ', Journal of Thoracic Oncology, vol. 12, no. 4, pp. 752-762 . https://doi.org/10.1016/j.jtho.2016.12.017Test
Peters, S, Stahel, R A, Dafni, U, Ponce Aix, S, Massutí, B, Gautschi, O, Coate, L, López Martín, A, van Heemst, R, Berghmans, T, Meldgaard, P, Cobo Dols, M, Garde Noguera, J, Curioni-Fontecedro, A, Rauch, D, Mark, M T, Cuffe, S, Biesma, B, van Henten, A M J, Juan Vidal, Ó, Palmero Sanchez, R, Villa Guzmán, J C, Collado Martin, R, Peralta, S, Insa, A, Summers, Y, Láng, I, Horgan, A, Ciardiello, F, de Hosson, S, Pieterman, R, Groen, H J M, van den Berg, P M, Zielinski, C C, Chittazhathu Kurian Kuruvilla, Y, Gasca-Ruchti, A, Kassapian, M, Novello, S, Torri, V, Tsourti, Z, Gregorc, V, Smit, E F & EMPHASIS-lung Collaborative Group 2017, ' Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial ', Journal of Thoracic Oncology, vol. 12, no. 4, pp. 752-762 . https://doi.org/10.1016/j.jtho.2016.12.017Test
Journal of Thoracic Oncology, 12(4), 752-762. ELSEVIER SCIENCE INC

مصطلحات موضوعية: Oncology, Male, Lung Neoplasms, medicine.medical_treatment, Docetaxel, NSCLC, THERAPY, Squamous, Cohort Studies, RETROSPECTIVE ANALYSIS, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, 3RD-LINE, Antineoplastic Combined Chemotherapy Protocols, VeriStrat, 030212 general & internal medicine, Erlotinib Hydrochloride, ETOP, Prognosis, Survival Rate, Erlotinib, 030220 oncology & carcinogenesis, Carcinoma, Squamous Cell, Female, Taxoids, Veristrat, 2ND-LINE TREATMENT, medicine.drug, Pulmonary and Respiratory Medicine, medicine.medical_specialty, 03 medical and health sciences, Internal medicine, Multicenter trial, medicine, TYROSINE KINASE INHIBITORS, Journal Article, Humans, Lung cancer, COMBINATION, Survival rate, neoplasms, METAANALYSIS, Aged, Neoplasm Staging, Platinum, Chemotherapy, business.industry, medicine.disease, respiratory tract diseases, business, GROWTH-FACTOR RECEPTOR, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee1d367d8bc33b24edc27d000909d5bdTest
https://pubmed.ncbi.nlm.nih.gov/28343541Test

المؤلفون: Di Maio, M, Leighl, Nb, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, Ms, Signoriello, S, Perrone, F, Gridelli, C, Torch, Investigators, Calabro', L

المساهمون: Di Maio, M., Leighl, N. B., Gallo, C., Feld, R., Ciardiello, F., Butts, C., Maione, P., Gebbia, V., Morgillo, F., Wierzbicki, R., Favaretto, A., Alam, Y., Cinieri, S., Siena, S., Bianco, Roberto, Riccardi, F., Spatafora, M., Ravaioli, A., Felletti, R., Fregoni, V., Genestreti, G., Rossi, A., Mancuso, G., Fasano, M., Morabito, A., Tsao, M. S., Signoriello, S., Perrone, F., Gridelli, C., Di Maio, M, Leighl, N, Gallo, C, Feld, R, Ciardiello, F, Butts, C, Maione, P, Gebbia, V, Morgillo, F, Wierzbicki, R, Favaretto, A, Alam, Y, Cinieri, S, Siena, S, Bianco, R, Riccardi, F, Spatafora, M, Ravaioli, A, Felletti, R, Fregoni, V, Genestreti, G, Rossi, A, Mancuso, G, Fasano, M, Morabito, A, Tsao, M, Signoriello, S, Perrone, F, Gridelli, C, Leighl, Nb

مصطلحات موضوعية: Oncology, Male, erlotinib, Lung Neoplasms, Health-related quality of life, NSCLC, chemotherapy, Deoxycytidine, law.invention, Randomized controlled trial, Quality of life, law, Carcinoma, Non-Small-Cell Lung, Surveys and Questionnaires, Antineoplastic Combined Chemotherapy Protocols, Surveys and Questionnaire, Quality of life analysis of TORCH, Erlotinib Hydrochloride, Prognosis, humanities, Research Design, Advanced non–small-cell lung cancer, Carcinoma, Squamous Cell, Female, Erlotinib, Randomized trial, medicine.drug, Human, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Prognosi, EGFR, First-line treatment, first-line erlotinib, second-line cisplatin/gemcitabine chemotherapy, Adenocarcinoma, NO, Follow-Up Studie, Internal medicine, advanced non-small-cell lung cancer, medicine, Humans, Lung cancer, Advanced non-small-cell lung cancer, Chemotherapy, Quality of life analysis of TORCH , first-line erlotinib , second-line cisplatin/gemcitabine chemotherapy, advanced non-small-cell lung cancer, Aged, Neoplasm Staging, Salvage Therapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Questionnaire, Cancer, Quinazoline, medicine.disease, Interim analysis, Gemcitabine, Surgery, Lung Neoplasm, quality of life, Quinazolines, Carcinoma, Large Cell, Cisplatin, Neoplasm Recurrence, Local, business, Follow-Up Studies

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::297e0496785c9c52225a929dbddaa27eTest
http://hdl.handle.net/11588/519780Test